Overseas Results Boost Abbott

Abbott Labs’ quarterly net rose 34% amid fewer charges and strong international results, thanks in part to the weak U.S. dollar. Sales of anti-inflammatory drug Humira surged.

Posted on April 17th, 2008 by
Filed under: stock news